Sitomet Tablet 50 mg + 500 mg is a fixed-dose combination therapy containing Sitagliptin and Metformin Hydrochloride for the management of type 2 diabetes mellitus. Sitagliptin, a DPP-4 inhibitor, enhances insulin secretion and suppresses glucagon release in a glucose-dependent manner, while Metformin improves insulin sensitivity and reduces hepatic glucose production.

This combination is ideal for patients whose blood sugar is not adequately controlled by diet, exercise, or monotherapy. Sitomet helps lower both fasting and postprandial glucose levels while minimizing the risk of hypoglycemia, providing effective long-term glycemic control.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition

• Sitagliptin 50 mg
• Metformin Hydrochloride 500 mg

Mechanism of Action

Sitagliptin:

• Inhibits DPP-4 enzyme, increasing incretin hormones (GLP-1, GIP).
• Stimulates insulin secretion after meals and reduces glucagon secretion, lowering blood glucose.

Metformin:

• Reduces hepatic glucose production
• Enhances peripheral glucose uptake, improving insulin sensitivity
• Slightly delays intestinal glucose absorption

The combination provides a complementary effect, improving overall glycemic control in type 2 diabetes.

Indications

Sitomet Tablet is indicated for:

• Adults with type 2 diabetes mellitus not controlled by diet and exercise alone
• Patients requiring dual therapy for better control of fasting and postprandial glucose
• Combination therapy as part of lifestyle modification to reduce diabetes-related complications

Dosage & Administration

• Typically, 1 tablet twice daily with meals, or as prescribed by the physician
• Taking the tablet with food helps reduce gastrointestinal side effects from Metformin
• Dose adjustment may be needed in patients with renal or hepatic impairment
• Regular monitoring of blood glucose, HbA1c, and kidney function is advised
• Maintain diet and exercise regimen for optimal results

Benefits

• Dual-action therapy addresses both insulin secretion and insulin resistance
• Improves fasting and postprandial blood sugar control
• Reduces risk of long-term diabetes complications
• Convenient fixed-dose formulation enhances patient compliance
• Lower risk of hypoglycemia compared to sulfonylurea-based therapies

Possible Side Effects

Common side effects:

• Nausea, vomiting, diarrhea, or abdominal discomfort
• Headache
• Mild dizziness

Rare but serious side effects:

• Lactic acidosis (very rare, associated with Metformin in kidney impairment)
• Allergic reactions (rash, swelling, itching)
• Hypoglycemia (rare when used alone, more likely with additional antidiabetic drugs)

Precautions & Warnings

• Avoid in patients with severe renal or hepatic impairment
• Not recommended for type 1 diabetes or diabetic ketoacidosis
• Use with caution during acute illness, dehydration, or excessive alcohol intake
• Monitor kidney function regularly due to Metformin content
• Discontinue immediately if symptoms of lactic acidosis occur
• Inform your doctor about all other medications being taken

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Storage

• Store at 20–25°C in a dry, cool place
• Keep tablets in original packaging until use
• Protect from heat, moisture, and sunlight
• Keep out of reach of children

Conclusion

Sitomet Tablet 50 mg + 500 mg (Sitagliptin + Metformin Hydrochloride) provides effective dual-action therapy for type 2 diabetes mellitus. Combining glucose-dependent insulin enhancement with improved insulin sensitivity, it ensures better blood sugar control, reduces complications, and offers convenient dosing for long-term management.